← All diseases Cancer

Chronic lymphocytic leukemia

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchStrongest evidence only (63)Meta-analysis (7)Treatment guideline (3)Phase 3 study (32)Systematic review (13)Randomized trial (8)Clinical trial (588)Review article (208)Early study (phase 1 or 2) (38)Case report (197)Laboratory or animal study (14)Commentary or editorial (62)Retracted publication (2) Studies currently seeking participants only (43)

Filter

Publications and studies (1769)

• Ibrutinib and venetoclax in combination for chronic lymphocytic leukemia: synergy in practice. (2024/09/01) ♡
• MicroRNA Profiling as a Predictive Indicator for Time to First Treatment in Chronic Lymphocytic Leukemia: Insights from the O-CLL1 Prospective Study. (2024/08/23) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Blinatumomab after R-CHOP bridging therapy for patients with Richter transformation: a phase 2 multicentre trial. (2024/08/09) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Composite Extranodal Natural Killer (NK)/T-cell Lymphoma and Chronic Lymphocytic Leukemia in Nasal Cavity: A Rare Case. (2024/08/01) ♡
• Network meta-analysis of novel targeted therapies for relapsed/refractory chronic lymphocytic leukemia. (2024/07/31) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Chronic Lymphocytic Leukemia: Prognostic Factors in the Era of Novel Drugs. (2024/07/31) ♡
• Vitamin D supplement for patients with early-stage chronic lymphocytic leukemia is associated with a longer time to first treatment. (2024/07/23) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Vitamin D insufficiency in CLL: a modifiable prognostic factor? (2024/07/23) ♡
• CD49d expression is included in a revised 4-factor model predicting outcome in patients with chronic lymphocytic leukemia treated with ibrutinib: A multicenter real-world experience. (2024/07/15) ♡
• The Utility of CD43 and CD200 in Differentiating Chronic Lymphocytic Leukemia from Other Mature B-Cell Neoplasms: A Cross Sectional Study. (2024/07/01) ♡
• Impact of ibrutinib dose adjustment on TTNT in first-line CLL/SLL: a real-world analysis using target trial emulation. (2024/06/10) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Biological, prognostic, and therapeutic impact of the epigenome in CLL. (2024/06/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Role of the tumor microenvironment in CLL pathogenesis. (2024/06/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Vitamin B12 Deficiency-Induced Neuropathy and Cognitive and Motor Impairment in the Elderly: A Case Study. (2024/06/01) ♡
• Multiple myeloma, haematologic malignancy and immunosuppressant and immunomodulatory medications are associated with sebaceous carcinoma, a pharmacovigilance study of the FDA adverse event reporting system. (2024/05/01) ♡
• Cutaneous squamous cell carcinoma tumor accrual rates in immunosuppressed patients with autoimmune and inflammatory conditions: A retrospective cohort study. (2024/04/01) ♡
• Caring for an Individual with Chronic Lymphocytic Leukemia (CLL): Understanding Family Caregivers' Perceptions of Social Support, Caregiver Burden, and Unmet Support Needs. (2024/04/01) ♡
• Plain language summary of zanubrutinib or ibrutinib in chronic lymphocytic leukemia that is resistant to treatment or has come back after treatment. (2024/04/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A diagnostic challenge-First case of chronic lymphatic leukemia-associated necrotizing sweet syndrome. (2024/04/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Telomere length and cancer risk: finding Goldilocks. (2024/04/01) ♡
• Investigation of fatty acid metabolism in chronic lymphocytic leukemia to guide clinical outcome and therapy. (2024/04/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. B-cell receptor immunoglobulin stereotypy in chronic lymphocytic leukemia: Key to understanding disease biology and stratifying patients. (2024/04/01) ♡
• Cyclic Fasting-Mimicking Diet Plus Bortezomib and Rituximab Is an Effective Treatment for Chronic Lymphocytic Leukemia. (2024/04/01) ♡
• TOX as a new diagnostic marker for T cell large granular lymphocytic leukaemia. (2024/03/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Richter's transformation: Transforming the clinical landscape. (2024/03/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Small lymphocytic lymphoma infiltrating gastrointestinal tract and mimicking inflammatory bowel disease, successfully treated with acalabrutinib. (2024/03/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Impact of targeted agents on survival of chronic lymphocytic leukemia patients age >65 relative to age- and sex-matched population. (2024/03/01) ♡
• Quantification of Measurable Residual Disease Detection by Next-Generation Sequencing-Based Clonality Testing in B-Cell and Plasma Cell Neoplasms. (2024/03/01) ♡
• Successful Management of Ibrutinib-Induced Thrombocytopenia in a Patient with Chronic Lymphocytic Leukemia: No Interruption, Only Reduction. (2024/03/01) ♡
• TIGIT is Frequently Expressed in the Tumor Microenvironment of Select Lymphomas: Implications for Targeted Therapy. (2024/03/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Mortality trends of chronic lymphocytic leukaemia in the United States with the emergence of targeted therapy. (2024/03/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Breast Cancer and Chronic Lymphocytic Leukemia and Renal Cell Carcinoma: A Case Report of a Rare Cancer Combination. (2024/02/09) ♡
• The role of Siglec-G on B cells in autoimmune disease and leukemia. (2024/02/01) ♡
• Real world analysis on the determinants of survival in primary plasma cell leukemia in the United States. (2024/02/01) ♡
• The presenting symptom signatures of incident cancer: evidence from the English 2018 National Cancer Diagnosis Audit. (2024/02/01) ♡
• ACOX1-mediated peroxisomal fatty acid oxidation contributes to metabolic reprogramming and survival in chronic lymphocytic leukemia. (2024/02/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Untangling hairy cell leukaemia (HCL) variant and other HCL-like disorders: Diagnosis and treatment. (2024/02/01) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Japanese phase Ib study of the oral PI3K-δ and -γ inhibitor duvelisib in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma. (2024/02/01) ♡
• Phase 3 studyiResearch in a large group of patients, the final step before a treatment can be approved. What comes out here carries significant weight. Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease. (2024/01/25) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Machine learning and multi-omics data in chronic lymphocytic leukemia: the future of precision medicine? (2024/01/12) ♡
• Integrative NGS testing reveals clonal dynamics of adverse genomic defects contributing to a natural progression in treatment-naïve CLL patients. (2024/01/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Six Years of Disease-free Survival After a Second Cord Blood Transplantation for Recurrent Acute Lymphocytic Leukemia in a Child With Down Syndrome. (2024/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Pathogenesis and management of immune dysfunction secondary to B cell haematological malignancies. (2024/01/01) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Tislelizumab plus zanubrutinib for Richter transformation: the phase 2 RT1 trial. (2024/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Duvelisib: A comprehensive profile. (2024/01/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Monoclonal Gammopathy of Renal Significance (MGRS) - Case Series from a Tertiary Center in Kerala. (2024/01/01) ♡
• Lifetime exposure to brominated trihalomethanes in drinking water and swimming pool attendance are associated with chronic lymphocytic leukemia: a Multicase-Control Study in Spain (MCC-Spain). (2024/01/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Ibrutinib as first line therapy in chronic lymphocytic leukemia patients over 80 years old: A retrospective real-life multicenter Italian cohort. (2024/01/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. The impact of acquired immunodeficiency in a patient with b-cell chronic lymphocytic leukemia on the course of coronavirus disease (COVID-19): a case report. (2024/01/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [HLA-haploidentical allogeneic hematopoietic stem cell transplantation using FluMelTBI conditioning for an elderly patient with fulminant aplastic anemia during treatment for chronic lymphocytic leukemia]. (2024/01/01) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.